Drug pricing system unchanged under KORUS FTA

The government may not change the basic framework of the current drug pricing system even under the Korea and United States FTA treaty.

Mr. Bae Gyeong-taek, the team head of MOHW's KORUS FTA said in the 1st pharma forum held at SNU College of Pharmacy on May 17 under the subject of "the Korea future and pharmaceutical industry" that the pharmaceutical, medical service and drugs were closely ...